-
-
SHOP
CE mark approval
2025-05-02Celnovte Achieves CE Mark for Innovative IHC Products
Celnovte Biotechnology is proud to announce that our range of immunohistochemistry (IHC) products has officially achieved CE Mark certification. This milestone reinforces our dedication to delivering high-quality, reliable solutions for pathology and cancer diagnostics across Europe.
Our CE-marked IHC product portfolio includes primary antibodies, detection systems, and automated stainers, designed to meet the stringent quality and safety requirements set by the European Union. This certification demonstrates our commitment to compliance with the In Vitro Diagnostic Regulation (IVDR), ensuring that our IHC products are safe, effective, and meet the needs of our clinical and laboratory customers.
With over 14 years of experience in the IVD industry and a strong global presence, Celnovte continues to provide state-of-the-art technology that enhances diagnostic accuracy and supports precision medicine. Our CE-certified IHC products are backed by rigorous quality control and validated performance, offering laboratories peace of mind and improved workflow efficiency.
By obtaining the CE Mark, Celnovte reaffirms our position as a trusted partner in the global pathology market, supporting healthcare professionals and laboratories in delivering superior diagnostic services. Explore our CE-marked IHC solutions today and discover how we can help elevate your laboratory’s capabilities.
Download
